Well, sort of. According to reports, KaloBios Pharmaceuticals has reportedly filed for Chapter 11 bankruptcy listing more than $1.9m in debt and more than $8.1m in assets. Trouble for the company is mounting, considering, Nasdaq informed the company that because of Shrkeli’s deceit on the stock market — they would be delisted come 25 December.
Martin Shrkeli’s former drug company goes under
Well, sort of. According to reports, KaloBios Pharmaceuticals has reportedly filed for Chapter 11 bankruptcy listing more than $1.9m in debt and more than $8.1m in assets. Trouble for the company is mounting, considering, Nasdaq informed the company that because of Shrkeli’s deceit on the stock market — they would be delisted come 25 December.
More from Your take?More posts in Your take? »
- American basketball star Britney Griner sentenced to 9 years in prison for possession of pot in Russia + swap details emerge
- A Japanese volcano has erupted resulting in widespread emergency alerts in the area
- Netflix’s stock has plunged more than 35% + global password sharing block coming
- This is not a drill Bridgerton Season 2 is coming (and Lady Whistledown announced it)
- Clemency has been granted to #JuliusJones as case renews calls for a deeper look at the tragic state of the #deathpenalty in America
Be First to Comment